Todd McDevitt, PhD

Todd McDevitt, PhD is a prominent figure in the field of stem cell biology and regenerative medicine with over 20 years of experience. He currently serves as the Vice President and Head of Cell Therapy at Genentech, a position he has held since August 2023.4

Career Highlights

Dr. McDevitt's career has spanned academia and industry:

• Genentech: Currently Vice President, Head of Cell Therapy (August 2023 - Present)4

• Sana Biotechnology:

  • Vice President, Head of Cell Engineering in SanaX (October 2021 - August 2023)
  • Site Leader, South San Francisco site (April 2022 - May 2023)4

• Gladstone Institutes:

  • Senior Investigator (December 2014 - October 2021)
  • Affiliate Investigator (November 2021 - October 2022)4

• University of California, San Francisco:

  • Professor, Department of Bioengineering and Therapeutic Sciences (January 2015 - October 2021)
  • Program Director, UCSF Bioengineering Graduate Program (December 2017 - October 2021)4

• Georgia Institute of Technology and Emory University:

  • Professor (July 2014 - December 2014)
  • Associate Professor (July 2010 - June 2014)
  • Assistant Professor (August 2004 - June 2010)4

Research Focus

Dr. McDevitt's research has focused on engineering technologies that direct the differentiation and morphogenesis of stem cells into functional tissue constructs.1 His work aims to create human tissue models for studying development and new approaches to treat diseases affecting various systems, including cardiovascular, neurological, immunological, and musculoskeletal.13

Education

• PhD in Bioengineering, University of Washington (1997-2001)
• BSE in Biomedical & Electrical Engineering, Duke University (1993-1997)4

Achievements and Recognition

Dr. McDevitt has received several honors and awards throughout his career, including:

• California Institute of Regenerative Medicine (CIRM) Research Leadership Award
• Induction into the American Institute of Medical and Biological Engineering College of Fellows
• Society for Biomaterials Young Investigator Award
• American Heart Association New Investigator Award1

His research has been widely cited, with several highly influential papers in the fields of stem cell biology, tissue engineering, and regenerative medicine.2

Todd McDevitt's career trajectory demonstrates his significant contributions to the field of stem cell engineering and his ability to bridge academic research with industry applications in the development of novel cell therapies.